The Journal of ECT最新文献_第4页

Rivaroxaban for Treatment of Pulmonary Embolism While Receiving Electroconvulsive Therapy. 利伐沙班在接受电休克治疗时治疗肺栓塞。

The Journal of ECT Pub Date : 2017-09-01 DOI: 10.1097/YCT.0000000000000396

E. Shao, Rachael L Moore, J. Linnane

引用次数: 3

Benefits of Dexmedetomidine in Management of Post-ECT Agitation 右美托咪定治疗电痉挛后躁动的益处

The Journal of ECT Pub Date : 2017-09-01 DOI: 10.1097/YCT.0000000000000393

Puneet Narang, F. Ianovich, S. Sarai, S. Lippmann

引用次数: 6

Switching From Age-Based Stimulus Dosing to Dose Titration Protocols in Electroconvulsive Therapy: Empirical Evidence for Better Patient Outcomes With Lower Peak and Cumulative Energy Doses 电休克治疗中从基于年龄的刺激剂量转向剂量滴定方案:较低峰值和累积能量剂量对患者预后更好的经验证据

The Journal of ECT Pub Date : 2017-09-01 DOI: 10.1097/YCT.0000000000000391

A. O’Neill-Kerr, Anhar Yassin, S. Rogers, J. Cornish

引用次数: 9

Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial 每天两次对一次高频重复经颅磁刺激治疗难治性抑郁症:一项随机假对照试验

The Journal of ECT Pub Date : 2017-09-01 DOI: 10.1097/YCT.0000000000000387

C. Theleritis, P. Sakkas, T. Paparrigopoulos, S. Vitoratou, C. Tzavara, S. Bonaccorso, A. Politis, C. Soldatos, Costantin Psarros

{"title":"Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial","authors":"C. Theleritis, P. Sakkas, T. Paparrigopoulos, S. Vitoratou, C. Tzavara, S. Bonaccorso, A. Politis, C. Soldatos, Costantin Psarros","doi":"10.1097/YCT.0000000000000387","DOIUrl":"https://doi.org/10.1097/YCT.0000000000000387","url":null,"abstract":"Objectives High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) has proven antidepressant effects, but the optimal frequency of sessions remains unclear. Methods We conducted a 3-week, sham-controlled trial to assess the antidepressant efficacy of 1 active HF-rTMS session per day (A1 group) compared with 2 per day (A2 group) and equivalent sham sessions (once a day, S1 group; twice a day, S2 group) in patients with treatment-resistant major depression with a subsequent 2-week follow-up period. One hundred seventy-seven patients were screened, of whom 105 met eligibility criteria and 98 consented and were randomized. The HF-rTMS (20 Hz) was targeted to the left prefrontal cortex in sessions of approximately 40 trains (2 seconds each) at 100% resting motor threshold with an intertrain interval of 1 minute. Treatment response was defined as a 50% or greater decrease in the Hamilton Depression Rating Scale (HDRS) score and/or Clinician Global Impressions-Severity of Illness (CGI-S) score of 3 or less. Remission was defined as HDRS score less than 8 and/or CGI-S score of 2 or less. Results Practically none of the subjects in either sham groups achieved remission. Increased odds of remission were present for CGI-S by stimulating twice rather than once per day (odds ratio [OR] = 1.5, P = 0.018), whereas there was a marginal result for HDRS (OR = 3.9, P = 0.066). Patients who had lower baseline HDRS (OR = 0.75, P = 0.014) and CGI-S scores (OR = 0.18, P = 0.001) were more likely to achieve remission. Conclusions Twice per day active HF-rTMS might be more effective than once per day active HF-rTMS or sham stimulation.","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122130575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 35

A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in England 英国电休克治疗的使用率进一步下降

The Journal of ECT Pub Date : 2017-09-01 DOI: 10.1097/YCT.0000000000000374

Nicky Buley, E. Copland, Sophie Hodge, R. Chaplin

{"title":"A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in England","authors":"Nicky Buley, E. Copland, Sophie Hodge, R. Chaplin","doi":"10.1097/YCT.0000000000000374","DOIUrl":"https://doi.org/10.1097/YCT.0000000000000374","url":null,"abstract":"Objectives Electroconvulsive therapy (ECT) is an effective treatment of major depression, and there have been consistent improvements in the administration of ECT in the past decade. However, studies have reported a steady decline in the rates of use of ECT in the United Kingdom and Ireland. Despite this, there has been no consistent record of how much ECT is being given or to whom it is given, for more than 20 years. The purpose of this study is to estimate the change in frequency of ECT use, the length of courses, patient demographics, and clinical outcomes between 2006 and 2 periods of 2012/2013 and 2014/2015. Methods In 2012/2013, clinics were asked to complete an online survey giving details of every patient who started a course of ECT between April 1, 2012, and March 31, 2013. This was repeated for the same period in 2014/2015. Results There continues to be a striking decline in the number of courses of ECT prescribed. Course length has increased. Women are twice as likely to be prescribed ECT as men. Modal age is 60 to 80 years, and the most common diagnosis is depression. Most courses were rated as clinically effective, especially for people with severe illnesses. Maintenance ECT is used at half the clinics surveyed. Conclusions The use of ECT in England continues to decline. The reasons for this are unclear and need investigation.","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123331475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 18

The Treatment of Disruptive Vocalization in Dementia (Behavioral and Psychological Symptoms of Dementia) With Electroconvulsive Therapy: A Case Series 电休克疗法治疗痴呆(痴呆的行为和心理症状)的破坏性发声:一个病例系列

The Journal of ECT Pub Date : 2017-06-01 DOI: 10.1097/YCT.0000000000000373

Timothy E. Lau, Prakash Kishor Babani, L. McMurray

{"title":"The Treatment of Disruptive Vocalization in Dementia (Behavioral and Psychological Symptoms of Dementia) With Electroconvulsive Therapy: A Case Series","authors":"Timothy E. Lau, Prakash Kishor Babani, L. McMurray","doi":"10.1097/YCT.0000000000000373","DOIUrl":"https://doi.org/10.1097/YCT.0000000000000373","url":null,"abstract":"Objective There is emerging evidence that electroconvulsive therapy (ECT) can help with the behavioral and psychological symptoms of dementia. One of the most distressing behavioral symptoms of dementia is disruptive vocalization. Previous small case series have suggested that antidepressants and ECT can be beneficial for this distressing condition. The aim of this study was to describe the successful use of ECT in treating 5 patients with disruptive vocalization. Methods A retrospective chart review of 5 patients with dementia of mixed etiologies was conducted comparing pretreatment and posttreatment scores on the Cohen-Mansfield Agitation Inventory. All 5 patients had unsuccessful treatments with nonpharmacological methods and pharmacotherapy including antidepressants. Results After completion of a series of ECT, the mean verbal agitation score decreased from 6.8 (95% confidence interval, 6.3–7.3) to 2.3 (95% confidence interval, 1.3–3.3), with both clinical and statistical significance (P < 0.001). Conclusions Although further research is needed, these findings support considering the use of ECT for disruptive vocalization in dementia.","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122421875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

The Journal of ECT Pub Date : 2017-06-01 DOI: 10.1097/YCT.0000000000000358

Chun-Jen Huang, Yu-hui Huang, Ching-Hua Lin

{"title":"Factors Related to the Changes in Quality of Life for Patients With Depression After an Acute Course of Electroconvulsive Therapy","authors":"Chun-Jen Huang, Yu-hui Huang, Ching-Hua Lin","doi":"10.1097/YCT.0000000000000358","DOIUrl":"https://doi.org/10.1097/YCT.0000000000000358","url":null,"abstract":"Objective The aim of this study was to examine the effect of electroconvulsive therapy (ECT) on quality of life (QOL), depressive symptoms, and functioning for patients with depression, and to explore the variables related to QOL changes. Methods Ninety-five inpatients with depression receiving at least 6 ECT sessions and completed all measures were included. Quality of life, symptom severity, and functioning were assessed using Short Form 36 (SF-36), the 17-item Hamilton Rating Scale for Depression (HAMD-17), and the Modified Work and Social Adjustment Scale (MWSAS), before and after ECT. The SF-36 includes 8 subscales, physical component summary (PCS), and mental component summary (MCS). Adverse effects after ECT, including headache, muscle pain, and nausea/vomiting, were also recorded. Results All 8 SF-36 subscales, PCS, MCS, HAMD-17, and MWSAS improved significantly after treatment. Using multiple linear regression analysis, MWSAS changes predicted PCS changes significantly after adjusting for baseline PCS. Similarly, using multiple linear regression analysis, MWSAS changes were significant variables associated with MCS changes after adjusting for ECT frequency, HAMD-17 changes, and baseline MCS. The ECT improved QOL, depressive symptoms, and functioning. Conclusions Whether strategies to enhance functioning during an acute course of ECT could improve QOL is needed to be examined in a further study.","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127689346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Electroconvulsive Therapy Practice in New Zealand 新西兰电休克疗法实践

The Journal of ECT Pub Date : 2017-06-01 DOI: 10.1097/YCT.0000000000000364

M. Fisher, J. Morrison, P. Jones

引用次数: 5

Electroconvulsive Therapy Considerations for Transgendered Patients. 跨性别患者的电休克治疗注意事项。

The Journal of ECT Pub Date : 2017-06-01 DOI: 10.1097/YCT.0000000000000371

Billy Tran, S. E. O'Donnell, Agnes Balla, David Adams, L. Grondin, Mitchell H. Tsai

{"title":"Electroconvulsive Therapy Considerations for Transgendered Patients.","authors":"Billy Tran, S. E. O'Donnell, Agnes Balla, David Adams, L. Grondin, Mitchell H. Tsai","doi":"10.1097/YCT.0000000000000371","DOIUrl":"https://doi.org/10.1097/YCT.0000000000000371","url":null,"abstract":"As the transgender patient population continues to grow, health care providers will need to become aware of elements unique to the transgender community in order to provide the highest quality of care. Neuromuscular blockade with succinylcholine is routinely administered to patients undergoing electroconvulsive therapy (ECT). Decreased amounts or activity of pseudocholinesterase in serum can lead to prolonged duration of muscle paralysis. Causes of reduced action by pseudocholinesterase include genetically abnormal enzymes, reduced hepatic production, pregnancy, and various drug interactions. Estrogen supplementation taken by transitioning patients may affect the duration of neuromuscular blockade.This is a case of a 32-year-old male-to-female transgender patient with prolonged apnea following ECT treatment for severe, refractory depression. Further investigation revealed the patient was on estrogen therapy as a part of her transition and laboratory testing demonstrated reduced serum pseudocholinesterase activity. Further laboratory testing demonstrated reduced serum pseudocholinesterase activity. Succinylcholine dosing was titrated to an appropriate level to avoid prolonged apnea in subsequent ECT treatments. Physicians and other health care providers are faced with a unique population in the transgender community and must be aware of distinctive circumstances when providing care to this group. Of specific interest, many transitioning and transitioned patients can be on chronic estrogen supplementation. Neuromuscular blockade in those patients require attention from the anesthesiology care team as estrogen compounds may decrease pseudocholinesterase levels and lead to prolonged muscle paralysis from succinylcholine.","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114293185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

A Successful Course of Electroconvulsive Therapy in a Patient With Epilepsy and a Posterior Fossa Titanium Plate. 一个成功的电痉挛治疗癫痫和后窝钛板的过程。

The Journal of ECT Pub Date : 2017-06-01 DOI: 10.1097/YCT.0000000000000382

R. Katz, Mesut Toprak, R. Ostroff

引用次数: 7